Increased expression of cancer stem cell (CSC) markers, including c-Met, CD133, CD44, EpCAM (also known as ESA), ALDH1, Nanog, Oct4 and SOX2, has been identified in PDA [7, 8]. This evidence concerns the gene ALDH1A1 and Patent ductus arteriosus.